Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Income	Total Rithm Capital Stockholders’ Equity	Noncontrolling Interests in Equity of Consolidated Subsidiaries
Preferred stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2020		33,610,000
Common stock, shares outstanding beginning balance (in shares) at Dec. 31, 2020			414,744,518
Equity, beginning balance at Dec. 31, 2020	$ 5,429,684	$ 812,992	$ 4,148	$ 5,547,108	$ (1,108,929)	$ 65,697	$ 5,321,016	$ 108,668
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared on common stock	(176,275)				(176,275)		(176,275)
Dividends declared on preferred stock	(28,716)				(28,716)		(28,716)
Capital distributions	(34,015)							(34,015)
Issuance of common stock (in shares)			51,725,000
Issuance of common stock	511,487		$ 517	510,970			511,487
Director share grants (in shares)			110,402
Director share grants	1,110		$ 2	1,108			1,110
Comprehensive income (loss)
Net income	447,062				427,615		427,615	19,447
Unrealized gain (loss) on available-for-sale securities, net	21,139					21,139	21,139
Reclassification of realized (gain) loss on available-for-sale securities, net into net income	(5,325)					(5,325)	(5,325)
Comprehensive income	462,876						443,429	19,447
Preferred stock, shares outstanding, Ending balance (in shares) at Jun. 30, 2021		33,610,000
Common stock, shares outstanding ending balance (in shares) at Jun. 30, 2021			466,579,920
Equity, ending balance at Jun. 30, 2021	6,166,151	$ 812,992	$ 4,667	6,059,186	(886,305)	81,511	6,072,051	94,100
Preferred stock, shares outstanding, beginning balance (in shares) at Mar. 31, 2021		33,610,000
Common stock, shares outstanding beginning balance (in shares) at Mar. 31, 2021			414,797,263
Equity, beginning balance at Mar. 31, 2021	5,621,813	$ 812,992	$ 4,149	5,547,607	(914,304)	72,385	5,522,829	98,984
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared on common stock	(93,316)				(93,316)		(93,316)
Dividends declared on preferred stock	(14,358)				(14,358)		(14,358)
Capital distributions	(14,937)							(14,937)
Issuance of common stock (in shares)			51,725,000
Issuance of common stock	511,487		$ 517	510,970			511,487
Director share grants (in shares)			57,657
Director share grants	610		$ 1	609			610
Comprehensive income (loss)
Net income	145,726				135,673		135,673	10,053
Unrealized gain (loss) on available-for-sale securities, net	9,949					9,949	9,949
Reclassification of realized (gain) loss on available-for-sale securities, net into net income	(823)					(823)	(823)
Comprehensive income	154,852						144,799	10,053
Preferred stock, shares outstanding, Ending balance (in shares) at Jun. 30, 2021		33,610,000
Common stock, shares outstanding ending balance (in shares) at Jun. 30, 2021			466,579,920
Equity, ending balance at Jun. 30, 2021	$ 6,166,151	$ 812,992	$ 4,667	6,059,186	(886,305)	81,511	6,072,051	94,100
Preferred stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2021	52,210,000	52,210,000
Common stock, shares outstanding beginning balance (in shares) at Dec. 31, 2021	466,758,266		466,758,266
Equity, beginning balance at Dec. 31, 2021	$ 6,669,380	$ 1,262,481	$ 4,669	6,059,671	(813,042)	90,253	6,604,032	65,348
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared on common stock	(233,411)				(233,411)		(233,411)	0
Dividends declared on preferred stock	(44,888)				(44,888)		(44,888)
Capital distributions	(15,968)							(15,968)
Preferred stock repurchase (in shares)		171,658
Preferred stock repurchase	(3,814)	$ (3,814)					(3,814)
Director share grants (in shares)			98,487
Director share grants	1,070		$ 1	1,069			1,070
Comprehensive income (loss)
Net income	723,262				703,471		703,471	19,791
Unrealized gain (loss) on available-for-sale securities, net	(32,633)					(32,633)	(32,633)
Reclassification of realized (gain) loss on available-for-sale securities, net into net income	0
Comprehensive income	$ 690,629						670,838	19,791
Preferred stock, shares outstanding, Ending balance (in shares) at Jun. 30, 2022	52,038,000	52,038,342
Common stock, shares outstanding ending balance (in shares) at Jun. 30, 2022	466,856,753		466,856,753
Equity, ending balance at Jun. 30, 2022	$ 7,062,998	$ 1,258,667	$ 4,670	6,060,740	(387,870)	57,620	6,993,827	69,171
Preferred stock, shares outstanding, beginning balance (in shares) at Mar. 31, 2022		52,038,342
Common stock, shares outstanding beginning balance (in shares) at Mar. 31, 2022			466,786,526
Equity, beginning balance at Mar. 31, 2022	7,184,712	$ 1,258,667	$ 4,669	6,059,981	(267,878)	67,195	7,122,634	62,078
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared on common stock	(116,714)				(116,714)		(116,714)
Dividends declared on preferred stock	(22,427)				(22,427)		(22,427)
Capital distributions	(7,089)							(7,089)
Director share grants (in shares)			70,227
Director share grants	760		$ 1	759			760
Comprehensive income (loss)
Net income	33,331				19,149		19,149	14,182
Unrealized gain (loss) on available-for-sale securities, net	(9,575)					(9,575)	(9,575)
Reclassification of realized (gain) loss on available-for-sale securities, net into net income	0
Comprehensive income	$ 23,756						9,574	14,182
Preferred stock, shares outstanding, Ending balance (in shares) at Jun. 30, 2022	52,038,000	52,038,342
Common stock, shares outstanding ending balance (in shares) at Jun. 30, 2022	466,856,753		466,856,753
Equity, ending balance at Jun. 30, 2022	$ 7,062,998	$ 1,258,667	$ 4,670	$ 6,060,740	$ (387,870)	$ 57,620	$ 6,993,827	$ 69,171